Tc-99m galactosyl-neoglycoalbumin: In vitro characterization of receptor-mediated binding

D. R. Vera, Kenneth Krohn, R. C. Stadalnik, P. O. Scheibe

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Hepatic binding protein (HBP) is a membrane receptor that binds and transports plasma glycoproteins from hepatic blood to hepatocellular lysosomes. We have characterized the in vitro binding of Tc-99m galactosyl-neoglycoalbumin (Tc-NGA), a synthetic HBP ligand, to liver membrane. Structural modifications of NGA resulted in the alteration of the equilibrium constant, K(A), and the forward-binding rate constant, k(b). Binding was second-order; the relative amount of membrane-bound NGA depended on the initial concentrations of ligand and membrane. Membrane displacement studies, using carrier ligands in contrast to previously bound Tc-NGA or I-NGA, correlated with the binding characteristics of a native HBP ligand, asialo-orosomucoid. We used computer simulation to study the detectability of the changes in HBP concentration at different values of k(b). The simulations indicated that radiopharmacokinetic sensitivity to alterations in [HBP] should be possible using a neoglycoalbumin preparation with a carbohydrate density within the range of 15 to 25 galactose units per albumin molecule.

Original languageEnglish (US)
Pages (from-to)779-787
Number of pages9
JournalJournal of Nuclear Medicine
Volume25
Issue number7
StatePublished - 1984
Externally publishedYes

Fingerprint

Membranes
Ligands
Liver
Lysosomes
Galactose
Computer Simulation
Albumins
Glycoproteins
Carbohydrates
In Vitro Techniques
hepatic sialoglycoprotein receptor
technetium Tc 99m neogalactoalbumin

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Tc-99m galactosyl-neoglycoalbumin : In vitro characterization of receptor-mediated binding. / Vera, D. R.; Krohn, Kenneth; Stadalnik, R. C.; Scheibe, P. O.

In: Journal of Nuclear Medicine, Vol. 25, No. 7, 1984, p. 779-787.

Research output: Contribution to journalArticle

Vera, D. R. ; Krohn, Kenneth ; Stadalnik, R. C. ; Scheibe, P. O. / Tc-99m galactosyl-neoglycoalbumin : In vitro characterization of receptor-mediated binding. In: Journal of Nuclear Medicine. 1984 ; Vol. 25, No. 7. pp. 779-787.
@article{923698fa0088403782df8d79341fb0e3,
title = "Tc-99m galactosyl-neoglycoalbumin: In vitro characterization of receptor-mediated binding",
abstract = "Hepatic binding protein (HBP) is a membrane receptor that binds and transports plasma glycoproteins from hepatic blood to hepatocellular lysosomes. We have characterized the in vitro binding of Tc-99m galactosyl-neoglycoalbumin (Tc-NGA), a synthetic HBP ligand, to liver membrane. Structural modifications of NGA resulted in the alteration of the equilibrium constant, K(A), and the forward-binding rate constant, k(b). Binding was second-order; the relative amount of membrane-bound NGA depended on the initial concentrations of ligand and membrane. Membrane displacement studies, using carrier ligands in contrast to previously bound Tc-NGA or I-NGA, correlated with the binding characteristics of a native HBP ligand, asialo-orosomucoid. We used computer simulation to study the detectability of the changes in HBP concentration at different values of k(b). The simulations indicated that radiopharmacokinetic sensitivity to alterations in [HBP] should be possible using a neoglycoalbumin preparation with a carbohydrate density within the range of 15 to 25 galactose units per albumin molecule.",
author = "Vera, {D. R.} and Kenneth Krohn and Stadalnik, {R. C.} and Scheibe, {P. O.}",
year = "1984",
language = "English (US)",
volume = "25",
pages = "779--787",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "7",

}

TY - JOUR

T1 - Tc-99m galactosyl-neoglycoalbumin

T2 - In vitro characterization of receptor-mediated binding

AU - Vera, D. R.

AU - Krohn, Kenneth

AU - Stadalnik, R. C.

AU - Scheibe, P. O.

PY - 1984

Y1 - 1984

N2 - Hepatic binding protein (HBP) is a membrane receptor that binds and transports plasma glycoproteins from hepatic blood to hepatocellular lysosomes. We have characterized the in vitro binding of Tc-99m galactosyl-neoglycoalbumin (Tc-NGA), a synthetic HBP ligand, to liver membrane. Structural modifications of NGA resulted in the alteration of the equilibrium constant, K(A), and the forward-binding rate constant, k(b). Binding was second-order; the relative amount of membrane-bound NGA depended on the initial concentrations of ligand and membrane. Membrane displacement studies, using carrier ligands in contrast to previously bound Tc-NGA or I-NGA, correlated with the binding characteristics of a native HBP ligand, asialo-orosomucoid. We used computer simulation to study the detectability of the changes in HBP concentration at different values of k(b). The simulations indicated that radiopharmacokinetic sensitivity to alterations in [HBP] should be possible using a neoglycoalbumin preparation with a carbohydrate density within the range of 15 to 25 galactose units per albumin molecule.

AB - Hepatic binding protein (HBP) is a membrane receptor that binds and transports plasma glycoproteins from hepatic blood to hepatocellular lysosomes. We have characterized the in vitro binding of Tc-99m galactosyl-neoglycoalbumin (Tc-NGA), a synthetic HBP ligand, to liver membrane. Structural modifications of NGA resulted in the alteration of the equilibrium constant, K(A), and the forward-binding rate constant, k(b). Binding was second-order; the relative amount of membrane-bound NGA depended on the initial concentrations of ligand and membrane. Membrane displacement studies, using carrier ligands in contrast to previously bound Tc-NGA or I-NGA, correlated with the binding characteristics of a native HBP ligand, asialo-orosomucoid. We used computer simulation to study the detectability of the changes in HBP concentration at different values of k(b). The simulations indicated that radiopharmacokinetic sensitivity to alterations in [HBP] should be possible using a neoglycoalbumin preparation with a carbohydrate density within the range of 15 to 25 galactose units per albumin molecule.

UR - http://www.scopus.com/inward/record.url?scp=0021245955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021245955&partnerID=8YFLogxK

M3 - Article

C2 - 6737077

AN - SCOPUS:0021245955

VL - 25

SP - 779

EP - 787

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 7

ER -